These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
888 related items for PubMed ID: 18974888
1. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS. PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888 [Abstract] [Full Text] [Related]
2. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Clin Infect Dis; 2005 Jul 01; 41 Suppl 1():S18-24. PubMed ID: 16265609 [Abstract] [Full Text] [Related]
3. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN. Clin Infect Dis; 2008 Jun 01; 46(11):1761-8. PubMed ID: 18433337 [Abstract] [Full Text] [Related]
4. [Study on the epidemiology and distribution of human immunodeficiency virus-1 and hepatitis C virus infection among intravenous drug users and illegal blood donors in China]. Yin N, Mei S, Li L, Wei FL, Zhang LQ, Cao YZ. Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov 01; 24(11):962-5. PubMed ID: 14687492 [Abstract] [Full Text] [Related]
5. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. de Vos AS, van der Helm JJ, Prins M, Kretzschmar ME. Epidemics; 2012 Jun 01; 4(2):57-67. PubMed ID: 22664064 [Abstract] [Full Text] [Related]
6. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil. Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF. J Clin Virol; 2009 Mar 01; 44(3):200-6. PubMed ID: 19195927 [Abstract] [Full Text] [Related]
7. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study. Ruan Y, Qin G, Yin L, Chen K, Qian HZ, Hao C, Liang S, Zhu J, Xing H, Hong K, Shao Y. AIDS; 2007 Dec 01; 21 Suppl 8():S39-46. PubMed ID: 18172390 [Abstract] [Full Text] [Related]
8. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China]. Li D, Zheng X, Zhang G. Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr 01; 15(2):74-5. PubMed ID: 7522968 [Abstract] [Full Text] [Related]
9. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia]. Huntington S, Folch C, González V, Meroño M, Ncube F, Casabona J. Enferm Infecc Microbiol Clin; 2010 Apr 01; 28(4):236-8. PubMed ID: 19695744 [Abstract] [Full Text] [Related]
10. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Vicknasingam B, Narayanan S, Navaratnam V. Drug Alcohol Rev; 2009 Jul 01; 28(4):447-54. PubMed ID: 19594801 [Abstract] [Full Text] [Related]
11. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low. Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B. J Med Virol; 2013 Oct 01; 85(10):1712-23. PubMed ID: 23868809 [Abstract] [Full Text] [Related]
12. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Cyprus IVDU Network, Kostrikis LG. J Med Virol; 2010 Feb 01; 82(2):263-70. PubMed ID: 20029809 [Abstract] [Full Text] [Related]
13. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. Mohsen AH, Murad S, Easterbrook PJ. HIV Med; 2005 May 01; 6(3):206-15. PubMed ID: 15876288 [Abstract] [Full Text] [Related]
14. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users. Backmund M, Meyer K, Henkel C, Reimer J, Wächtler M, Schütz CG. Eur Addict Res; 2005 May 01; 11(3):138-44. PubMed ID: 15990431 [Abstract] [Full Text] [Related]
15. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. J Infect; 2009 May 01; 58(5):375-82. PubMed ID: 19328555 [Abstract] [Full Text] [Related]
16. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia. Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV. Int J STD AIDS; 2005 Nov 01; 16(11):749-54. PubMed ID: 16303071 [Abstract] [Full Text] [Related]
17. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S. Isr Med Assoc J; 2008 Nov 01; 10(11):775-8. PubMed ID: 19070285 [Abstract] [Full Text] [Related]
18. Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China. Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S, Huang M, Qin C, Yan R, Zhu X, Zhang C. J Clin Virol; 2012 Jul 01; 54(3):207-12. PubMed ID: 22595306 [Abstract] [Full Text] [Related]
19. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. Lee YM, Lin HJ, Chen YJ, Lee CM, Wang SF, Chang KY, Chen TL, Liu HF, Chen YM. J Med Virol; 2010 Jan 01; 82(1):57-68. PubMed ID: 19950240 [Abstract] [Full Text] [Related]
20. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users. Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, Des Jarlais DC. Int J STD AIDS; 2006 Sep 01; 17(9):621-6. PubMed ID: 16942654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]